C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups

Patents for C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
12/2014
12/17/2014	CN104211655A 具有抗菌和抗肿瘤活性的新大环内酯化合物 New macrolide compounds with antibacterial and anti-tumor activity
05/2014
05/14/2014	EP2730564A1 Heterocycle amines and uses thereof
09/2013
09/25/2013	EP2640708A1 Heterocycle amines and uses thereof
09/11/2013	CN103298792A Heterocycle amines and uses thereof
08/2013
08/01/2013	US20130196965 Cyclic amides
06/2013
06/05/2013	EP2598661A2 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
06/05/2013	EP2598660A2 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
11/2012
11/14/2012	CN102781441A Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same
09/2012
09/19/2012	CN101528740B Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
09/05/2012	CN102653526A 2, 3-diaryl thiazolinone compound and usage thereof in preparation of medicine for treating tumour
08/2012
08/09/2012	WO2012018638A3 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
08/08/2012	EP2482813A1 Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same
07/2012
07/26/2012	WO2012097510A1 Process for preparation of efavirenz by cyclisation
07/05/2012	WO2012018639A3 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
05/2012
05/24/2012	WO2012068546A1 Heterocycle amines and uses thereof
04/2012
04/18/2012	EP1960375B1 Novel macrolide compounds with antibiotic and antneoplastic properties
02/2012
02/09/2012	WO2012018639A2 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
02/09/2012	WO2012018638A2 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
02/09/2012	CA2806734A1 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
02/09/2012	CA2806670A1 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
10/2011
10/18/2011	US8039454 Macrolide compounds with antibiotic and antineoplastic properties
05/2011
05/12/2011	US20110112090 Depsipeptides and Their Therapeutic Use
04/2011
04/07/2011	WO2011041369A1 Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same
04/07/2011	CA2775925A1 Salts, solvates and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same
03/2011
03/31/2011	WO2010127088A3 Intramolecular azide-alkyne cycloaddition
01/2011
01/04/2011	CA2488363C O-substituted hydroxyaryl derivatives
11/2010
11/04/2010	WO2010127088A2 Intramolecular azide-alkyne cycloaddition
05/2010
05/06/2010	US20100113770 O-substituted hydroxyaryl derivatives
04/2010
04/28/2010	CN1658855B O-substituted hydroxyaryl derivatives
02/2010
02/17/2010	EP2152680A2 Method for preparing enantiomerically enriched<i>n</i>-carboxyanhydride
12/2009
12/01/2009	US7626042 O-substituted hydroxyaryl derivatives
11/2009
11/05/2009	US20090275648 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
10/2009
10/22/2009	US20090264644 Novel Macrolide Compounds With Antibiotic and Antineoplastic Properties
06/2009
06/25/2009	WO2009078498A1 Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands
04/2009
04/09/2009	WO2009004141A3 Method for preparing enantiomerically enriched n-carboxyanhydride
01/2009
01/08/2009	WO2009004141A2 Method for preparing enantiomerically enriched n-carboxyanhydride
12/2008
12/17/2008	CN101326170A Novel macrolide compounds with antibiotic and antneoplastic properties
09/2008
09/04/2008	WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists
09/02/2008	CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008	US20080207584 Compound Having S1P Receptor Binding Potency and Use Thereof
08/27/2008	EP1960375A1 Novel macrolide compounds with antibiotic and antneoplastic properties
04/2008
04/03/2008	WO2008039023A1 Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists
02/2008
02/21/2008	US20080045585 Macrocyclic Compounds And Methods Of Making And Using The Same
10/2007
10/04/2007	DE102006014335A1 Verdichtung von Sauerstoff Compression of oxygen
09/2007
09/05/2007	EP1828155A2 Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use
07/2007
07/24/2007	US7247744 Reacting a probucol derivatives with succinic, glutaric, adipic, suberic, sebacic, azelaic, phthalic or maleic anhydride in the presence of a prophosphatrane to form a water soluble mono- or bis(carboxyalkanoyl ester)
06/2007
06/21/2007	WO2007068084A1 Novel macrolide compounds with antibiotic and antneoplastic properties
01/2007
01/03/2007	CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/2006
09/08/2006	WO2006055542A3 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
08/2006
08/23/2006	CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
05/2006
05/26/2006	CA2574535A1 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
05/04/2006	US20060094718 O-substituted hydroxyaryl derivatives
11/2005
11/01/2005	CA2130166C Surface coatings and a process for their production
08/2005
08/24/2005	CN1658855A O-substituted hydroxyaryl derivatives
03/2005
03/09/2005	EP1512397A1 O-substituted hydroxyaryl derivatives
09/2004
09/07/2004	CA2151149C Novel ring opening monomers
05/2004
05/06/2004	EP1415991A1 Process for the purification of N-carboxyanhydrides
05/04/2004	US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
03/2004
03/16/2004	US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
01/2004
01/01/2004	US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
12/2003
12/18/2003	WO2003103656A1 O-substituted hydroxyaryl derivatives
10/2003
10/28/2003	US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2003
08/21/2003	US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
02/2003
02/11/2003	US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
03/2002
03/20/2002	EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors
11/2001
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
05/2001
05/22/2001	US6235778 Anticoagulants
12/2000
12/19/2000	US6162425 A keratin-reducing agent without allergic and sensitizing reactions
09/2000
09/06/2000	EP0675885B1 Novel ring opening monomers
12/1999
12/08/1999	CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
09/1999
09/29/1999	EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
01/1999
01/27/1999	EP0893118A1 Saturated alkylsubstituted N-mercaptoacetyl-heterocycles, agent and method for permanently shaping hair based thereon and processes for their preparation
07/1998
07/30/1998	WO1998023565A3 Aminoguanidines and alkoxyguanidines as protease inhibitors
06/1998
06/04/1998	WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
09/1997
09/09/1997	US5665839 Ring opening monomers
11/1996
11/19/1996	US5576431 Method for production of perfluoro-cyclic imine
10/1996
10/10/1996	WO1996031482A1 Novel heterocyclic compounds
10/1995
10/11/1995	EP0675885A1 Novel ring opening monomers
05/1995
05/02/1995	US5412056 Surface coatings and a process for their production
02/1995
02/22/1995	EP0639628A1 Process for preparing coatings
11/1994
11/24/1994	WO1994026719A1 Mercapto-amide derivatives useful as neutral endopeptidase and ace inhibitors
07/1994
07/13/1994	EP0357750B1 Urethane-protected amino acid-n-carboxyanhydrides
07/07/1994	WO1994014792A1 Novel ring opening monomers
10/1993
10/13/1993	CN1022412C Method for preparing urethane-protected amino acid-N-carboxyanhydrides
08/1993
08/10/1993	CA1321280C Urethane-protected amino acid-n-carboxyanhydrides
02/1991
02/26/1991	US4996315 Novel synthesis of cyclic compounds
01/1991
01/30/1991	EP0357750A4 Urethane-protected amino acid-n-carboxyanhydrides
10/1990
10/03/1990	CN1009824B Process for production of n,n-disubstd. carboxylic acid amides
08/1990
08/07/1990	US4946942 Urethane-protected amino acid-N-carboxyanhydrides
03/1990
03/28/1990	CN1040793A Method for preparing urethane-protected amino acid-n-carboxyanhydrides
03/14/1990	EP0357750A1 Urethane-protected amino acid-n-carboxyanhydrides.
09/1989
09/21/1989	WO1989008643A1 Urethane-protected amino acid-n-carboxyanhydrides
01/1989
01/18/1989	EP0299379A1 Pentadienamide PAF-antagonists
01/10/1989	CA1248414A1 Process for activating substrate surfaces for electroless metallisation
11/1988
11/29/1988	US4788206 Pentadieneamides
06/1988
06/14/1988	CA1238046A1 Dihydropyridyl cyclic imidate esters and their pharmaceutical use
04/1987
04/28/1987	US4661384 Organometallic compound with a guest-host ineterrelationship
08/1986
08/06/1986	EP0189774A1 Process for production of N,N-disubstituted carboxylic acid amides
07/1986
07/16/1986	CN86100282A Process for production of n,n-disubstitutted carboxylic acid amides
01/1986
01/02/1986	EP0166360A2 Process for activating substrates for electroless plating

1 2